A Pharmacokinetic Study of Baricitinib in Subjects With Hepatic Dysfunction
Phase of Trial: Phase I
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Baricitinib (Primary)
- Indications Diabetic nephropathies; Inflammation; Psoriasis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2013 New trial record
- 01 Jun 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.